Genenta Science SpA ADR
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-09-30 | 2024-12-31 |
|---|---|---|---|
Gross Profit | -14 | -12 | -23 |
EBITDA | -2,660 | -3,189 | -5,071 |
EBIT | -2,674 | -3,202 | -5,095 |
Net Income | -2,683 | -3,567 | -5,095 |
Free Cash Flow | -1,691 | -6,031 | -6,242 |
Cash | 5,527 | 5,176 | 4,581 |
Basic Shares | 21,218 | 18,767 | 18,290 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -26 | -46 | -41 | -5 |
EBITDA | -5,860 | -9,263 | -11,398 | -8,273 |
EBIT | -5,887 | -9,309 | -11,440 | -8,279 |
Net Income | -6,272 | -9,309 | -11,440 | -8,279 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,875 | -6,244 | -11,218 | -7,445 |
Cash | 5,527 | 4,581 | 3,691 | 29,794 |
Basic Shares | 19,710 | 18,273 | 18,216 | 18,216 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.20 |
2024-12-31 | -$0.27 |
2021-03-31 | -$0.16 |
2020-12-31 | -$0.16 |